Industry Update: Eli Lilly to Acquire Orna Therapeutics to Advance Cell Therapies
Industry Update: Providence Therapeutics Commences mRNA PCV Trial in Australia for Brain Cancers
Industry Update: CREATE Medicines Demonstrates B-Cell Depletion & Repeatable Dosing with In Vivo CAR-T
Industry Update: NeuCyte & Grann Pharma Enter Partnership for mRNA-Based Therapies for Rare Neurological Diseases
Industry Update: Adjuva Bio Awarded CELLSCRIPT™ 2026 mRNA Research Grant to Enhance Next-Gen In Vivo Cell Therapies

Eduardo Eyras

Eduardo Eyras

Director, Shine-Dalgarno Centre for RNA Innovation & Professor, EMBL-Australia Group Leader Australian National University

Seminars

Monday 20th July 2026

Biologically Informed AI models for mRNA design

2:00 pm

Domain-specific knowledge can facilitate more efficient training strategies and help improve the accuracy of AI models
Illustrating this with examples of AI models for mRNA property prediction and design
Discussing how to expand this strategy to other properties in the context of mRNA therapeutics

Eduardo Eyras - 6th mRNA-Based Therapeutics Summit Speaker

View all Speakers

View Event Brochure